Scientists from the Hebrew University of Jerusalem have generated an atlas of the human genome. It includes the roles that genes play in health and disease, plus the effect of over 180,000 gene mutations. http://www.jewishpress.com/news/israel/jerusalem/hebrew-u-scientists-use-stem-cells-to-generate-atlas-of-human-genome/2018/04/23/ https://www.nature.com/articles/s41556-018-0088-1

An Israeli-led international study has discovered that proteins called BMP5/7 are essential for the latest stem cell replacement therapy for Parkinson’s disease. The proteins help to stimulate the production of dopaminergic neurons, which Parkinson’s patients lack. https://www.israel21c.org/cell-discovery-holds-out-promise-for-parkinsons-therapy/ http://www.jneurosci.org/content/38/7/1662  

Professor Eitan Okun at Israel’s Bar-Ilan University has developed a vaccine that primes the body to attack amyloid beta protein accumulations in the brain, one of the signature signs of Alzheimer’s disease. He is also working on early diagnosis using … Continue reading →

I reported previously (28th Jan) that Israel’s Viz.ai had received the CE mark (European approval) for its brain scan analysis system for detecting strokes.  Now the US FDA has also approved the system. http://www.calcalistech.com/ctech/articles/0,7340,L-3736574,00.html

Tel Aviv University researchers have confirmed the effectiveness of bipolar depression sufferers combining mood stabilizers with anti-depressants. 81.7% of patients using both avoided re-hospitalization (for manic episodes), compared to only 57.6% of patients who did not receive the combination. https://www.israel21c.org/study-identifies-new-method-of-treating-bipolar-depression/ … Continue reading →

Israeli biotech Curewize successfully completed the clinical trial of its lead product ProALLBM on acute lymphoblastic leukemia (ALL) patients. ProALLBM reveals patients’ risk of relapse with just one bone marrow sample. They can then be given early treatment. https://www.bizjournals.com/newyork/prnewswire/press_releases/Georgia/2018/04/03/enUK201803265602?ana=prnews

I reported previously (3rd Sep) on the work of Israeli emergency NGO United Hatzalah’s Psychotrauma and Crisis Response Unit in Houston Texas.  Now the unit, headed by its director Miriam Ballin, is travelling to Johannesburg, South Africa to train 60 … Continue reading →

I reported previously (see here) on Israel’s MediSafe’s and its medication tracker app. Now the medical giant Merck KGaA is to work with MediSafe to develop a custom version of its mobile application for tracking treatment of cardiometabolic conditions. https://www.calcalistech.com/ctech/articles/0,7340,L-3735265,00.html